Literature DB >> 9367080

Advances in the diagnosis and treatment of adenocarcinoma of the pancreas.

D B Evans1, J E Lee, P W Pisters, C Charnsangavej, L M Ellis, P J Chiao, R Lenzi, J L Abbruzzese.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9367080     DOI： 10.1007/978-1-4615-6165-1_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  6 in total

1.  Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.

Authors:  Byoungduck Park; Bokyung Sung; Vivek R Yadav; Sung-Gook Cho; Mingyao Liu; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

2.  CD86 gene variants and susceptibility to pancreatic cancer.

Authors:  Honggang Xiang; Wei Zhao; Yanping Sun; Winnie Qian; Junjie Xing; Yujia Zhou; Jun Yao; Jian Xu; Yi Wang; Houshan Yao; Zhiqian Hu
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-21       Impact factor: 4.553

3.  TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

Authors:  Zhongkui Li; Zhe Chang; Lucia J Chiao; Ya'an Kang; Qianghua Xia; Cihui Zhu; Jason B Fleming; Douglas B Evans; Paul J Chiao
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

4.  Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

Authors:  Sung Yong Oh; Hyun Jin Kim; Tae Hyo Kim; Gyeong-Won Lee; Hoon Gu Kim; Chi-Young Jeong; Hyuk-Chan Kwon; Jung Hun Kang
Journal:  Invest New Drugs       Date:  2009-05-15       Impact factor: 3.850

5.  Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity.

Authors:  Yoichi Matsuo; Hirozumi Sawai; Nobuo Ochi; Akira Yasuda; Masaki Sakamoto; Hiroki Takahashi; Hitoshi Funahashi; Hiromitsu Takeyama; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

6.  Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.

Authors:  Ala Litman-Zawadzka; Marta Łukaszewicz-Zając; Mariusz Gryko; Agnieszka Kulczyńska-Przybik; Bogusław Kędra; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.